EP300 and cancer: In this review, we examined small-molecule inhibitors, summarized in Table 1, targeting CBP/β-catenin, p300/β-catenin, CBP/p300 bromodomain, and CBP/p300 HAT, highlighting their potential applications in cancer treatment.